Diabetes is a serious challenge for many children and teenagers.
Commission launches public consultation on Health and Care in the Digital Single Market
The European Commission launches a public consultation today on how Europe should promote digital innovation in health and care, for the benefits of citizens and of health systems in Europe. This consultation will help us to identify how to empower citizens, medical professionals and researchers; to ensure a right for citizens to have an electronic health record that they can access from everywhere in the EU, to improve prevention, rapid response to pandemic threats, personalised treatments and care.
- Press release
- Public Consultation: Transformation Health and Care in the Digital Single Market
- Digital Single Market - consultations
Innovative Medicines Initiative – new calls out
The Innovative Medicines Initiative has launched two Calls for proposals open, giving researchers from diverse sectors the opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future. The deadline for both calls is 24 October 2017, 17:00, Brussels time.
Antimicrobial Resistance: Commission steps us the fight with new Action Plan
The Commission continues to scale up its fight against antimicrobial resistance (AMR), with the launch of a second European Action Plan.
The new Action Plan is based on a One Health approach and focusses on supporting Member States, particularly in establishing, implementing and monitoring their National Action Plans. It also brings together EU funds and instruments to promote innovation and research against AMR and strengthen the EU's leading role in global fora, notably within the international organisations and with major trade partners.
Launch of the African Access Initiative
The Initiative along with a white paper on cancer burden and emerging crisis in Africa, was launched at BIO 2017 in San Diego. Through the European and Developing Countries Clinical Trials Partnership (EDCTP), the European Commission has been actively involved in sub-Saharan Africa. EDCTP's objective in that area is to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases.
- New African Access Initiative
- European and Developing Countries Clinical Trials Partnership
- BIO International Convention
€20 million EU loan to develop new device to quickly identify pathogens causing meningitis and other infectious diseases
An EU loan of €20 million will support a Barcelona-based start-up to develop and commercialise a device capable of identifying within an hour a range of infectious pathogens, such as those contained in meningitis, respiratory or gastro-intestinal infections. This loan is signed under the InnovFin Infectious Diseases Finance Facility.
Katholieke Universiteit Leuven (KU Leuven) and partners developing dual vaccine against yellow fever and rabies, supported by Horizon 2020
The RABYD-VAX consortium, led by KU Leuven, is developing a cheap and easy-to-produce vaccine against rabies AND yellow fever which allows a stable temperature during transport and storage and thus guarantees a better efficiency compared to the existing vaccines.
EMA publishes framework and action plan for closer interaction with academia
In the context of the European medicines regulatory network, the European Medicines Agency (EMA) has developed a framework and an action plan to reinforce collaboration with the academic community.
7-9 August 2017, Paris, France - 6th World Congress on Pharmacology
13-17 August 2017, Basel, Switzerland - WCS 2017 - World Congress of Surgery by ISS/SIC